Cell fractionation testing revealed that FOXD2‐AS1 was mainly located in the cytoplasm of HCC cells, implying that FOXD2‐AS1 might play a role in post‐transcriptional modification (Figure 3I). The gene discussed is FOXD2; the disease is hepatocellular carcinoma.